[Form 4/A] CONMED Corp Amended Insider Trading Activity
SHAGORY PETER K reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SHAGORY PETER K reported acquisition or exercise transactions in this Form 4 filing.
CONMED Corporation executive Peter K. Shagory received a corrected equity award totaling 16,926 restricted stock units (RSUs). Each RSU represents a right to receive one share of CONMED common stock under the Company’s 2025 Long-Term Incentive Plan.
The RSUs generally vest over three years, with 33% vesting one year after the grant date, another 33% in the second year, and 34% in the third year. This Form 4/A amends the prior report to reflect that a special award of 7,644 RSUs was granted in addition to the originally reported 9,282 RSUs, for the total 16,926 RSUs now shown as held directly following the transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | RSUs (Restricted Stock Units) | 16,926 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
- F2. This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.
AI-generated analysis. How Rhea-AI works. Not financial advice.